Follow-On
Underwritten Public Offering of 4,854,369 ADSs
On December 7, 2020, Sequans Communications S.A. (the
“Company”) entered into an underwriting agreement (the
“Underwriting Agreement”) with B. Riley Securities, Inc.
(the “Underwriter”), relating to an underwritten secondary
public offering of 2,529,961 American Depositary Shares (the
“ADSs”), each representing four ordinary shares, nominal
value €0.02 per share, of the Company. The ADSs are being sold by
Nokomis Capital Master Fund, L.P. (the “Selling
Shareholder”) The offering price to the public is $5.50
per ADS, and the Underwriters has agreed to purchase the ADSs
pursuant to the Underwriting Agreement at a price of $5.17 per
ADS. Under the terms of the Underwriting Agreement, the
Company granted the Underwriters a 30-day option to purchase up to an
additional 379,494 ADSs. The offering is expected to close on
December 10, 2020.
The net proceeds to the Company are expected to be approximately
$1.5 million if the underwriters exercise the over-allotment
option in full, after deducting underwriting discounts and
estimated offering expenses payable by the Company. If the
over-allotment option is exercised, the Company intends to use the
net proceeds to cover offering expenses and for general corporate
purposes.
The ADSs were offered and sold pursuant to the Company’s effective
shelf registration statement on Form F-3 (No. 333-333-250122), which was
previously filed with the Securities and Exchange Commission (the
“SEC”) on November 16, 2020 and declared effective by
the SEC on November 24, 2020, and a prospectus supplement
dated December 7, 2020 and filed with the SEC on
December 8, 2020 and accompanying base prospectus dated
November 24, 2020.
The Underwriting Agreement contains customary representations,
warranties, and agreements by the Company and the Selling
Shareholder, and customary conditions to closing, indemnification
obligations of the Company, the Selling Shareholder and the
Underwriter, including for liabilities under the Securities Act of
1933, as amended, other obligations of the parties, and termination
provisions.
The Underwriting Agreement is attached hereto as Exhibit 1.1 to
provide investors and security holders with information regarding
its terms and is incorporated herein by reference. It is not
intended to provide any other factual information about the
Company. The representations, warranties and covenants contained in
the Underwriting Agreement were made only for purposes of the
Underwriting Agreement and, as of specific dates, were solely for
the benefit of the parties to the Underwriting Agreement, and may
be subject to limitations agreed upon by the contracting
parties.
The foregoing description of the material terms of the Underwriting
Agreement does not purport to be complete and is qualified in its
entirety by reference to such exhibit. A copy of the legal
opinion and consent of Orrick, Herrington & Sutcliffe
(Europe) LLP relating to the ordinary shares represented by the
ADSs is attached hereto as Exhibit 5.1. The Company
issued press releases on December 7, 2020 and December 8,
2020 announcing the launch and pricing of the public
offering. These press releases are attached hereto as
Exhibit 99.1 and Exhibit 99.2, respectively, and are
incorporated herein by reference.
2